Helen of Troy (HELE) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Fiscal year 2025 marked the launch of the Elevate for Growth Strategy, targeting organic sales growth, margin expansion, and strategic capital deployment through acquisitions and share repurchases, with Project Pegasus supporting operational efficiencies and investment in brand capabilities.
Leadership transitioned in May 2025, with Brian Grass appointed interim CEO and Tracy Scheuerman as interim CFO, while a search for a permanent CEO is underway.
FY25 financial highlights: net sales of $1.91B, adjusted EBITDA of $289.3M, operating income of $142.7M, net income of $123.8M, and adjusted diluted EPS of $7.17.
The company completed the acquisition of Olive & June for $229M and repurchased over $100M in shares during FY25.
Voting matters and shareholder proposals
Shareholders will vote to elect eight directors, provide advisory approval of executive compensation, approve the 2025 Stock Incentive Plan, and appoint Grant Thornton LLP as auditor for FY26.
The board recommends voting FOR all proposals and nominees.
Shareholder proposals and director nominations for the 2026 meeting must comply with specific deadlines and requirements.
Board of directors and corporate governance
The board consists of eight independent directors with diverse backgrounds and 50% gender diversity.
Separate Chairman and CEO roles are maintained; all directors are elected annually by majority vote.
Four standing committees: Audit, Compensation, Nominating, and Governance, all composed of independent directors.
Regular executive sessions are held without management, and director stock ownership guidelines are enforced.
Shareholder engagement is ongoing through meetings, correspondence, and virtual annual meetings.
Latest events from Helen of Troy
- Prioritizing high-growth brands, revenue focus, and global expansion to drive long-term value.HELE
28th Annual ICR Conference 20263 Feb 2026 - Sales and earnings fell sharply, prompting lower guidance and continued restructuring.HELE
Q1 20253 Feb 2026 - All proposals passed as the company focuses on brand revitalization and operational transformation.HELE
AGM 202423 Jan 2026 - Q2 sales and margins fell, but guidance, cash flow, and $500M buyback remain on track.HELE
Q2 202519 Jan 2026 - $240M acquisition of a high-growth nail brand, immediately accretive and diversifying the portfolio.HELE
M&A Announcement12 Jan 2026 - Sales fell 3.4% as Home & Outdoor grew and Beauty & Wellness declined; guidance narrowed.HELE
Q3 202510 Jan 2026 - Brand revitalization, strategic acquisition, and operational efficiency drive growth and margin gains.HELE
27th Annual ICR Conference 202510 Jan 2026 - Q3 FY2026 net loss and margin pressure driven by asset impairments and tariff headwinds.HELE
Q3 20268 Jan 2026 - Q4 sales and adjusted EPS declined, FY26 faces $200M+ tariff risk with 70–80% mitigation planned.HELE
Q4 202523 Dec 2025